Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Juan Ignacio Esteban
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Disorders
Chemicals & Drugs
Anatomy
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
44
Esteban, Rafael
39
Guardia, Jaime
28
Sauleda, Silvia
17
Martell, María
16
Buti, Maria
14
Quer, Josep
11
Gómez, Jordi
9
Vargas, Víctor
8
Genesca, Joan
8
Allende, Helena
7
Cabot, Beatriz
7
Jardí, Rosendo
6
Genescà, Joan
5
Hernández, Cristina
5
Jardi, Rosendo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Juan Ignacio Esteban (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bes Marta; Esteban Juan Ignacio; Casamitjana Natàlia; Piron Maria; Quer Josep; Cubero María; Puig Lluís; Guardia Jaime; Sauleda Sílvia
Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.
Transfusion 2009;49(7):1296-305.
-
2009: Van den Eynde Eva; Crespo Manuel; Esteban Juan I; Jardi Rosend; Ribera Esteban; Carbonell Judit; Rodríguez-Frias Francisco; Falco Vicenç; Curran Adrià; Imaz Arkaitz; Villar del Saz Sara; Ocaña Inma; Esteban Rafael; Pahissa Albert
Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(8):1152-9.
-
2008: Diaz Olivier; Cubero Maria; Trabaud Mary Anne; Quer Josep; Icard Vinca; Esteban Juan I; Lotteau Vincent; André Patrice
Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection.
Journal of medical virology 2008;80(2):242-6.
-
2008: Quer Josep; Esteban Juan-Ignacio; Sánchez Josep-Maria; Otero Teresa; Rius Cristina; Coll Mar; Cubero Maria; Moreno Gina; Gonzalez Antonio; Vaque Josep; Esteban Rafael; Campins Magda; Pañella Helena; Guardia Jaume; Martell Maria
Nosocomial transmission of hepatitis C virus during contrast-enhanced computed tomography scanning.
European journal of gastroenterology & hepatology 2008;20(1):73-8.
-
2008: Esteban Juan I; Sauleda Silvia; Quer Josep
The changing epidemiology of hepatitis C virus infection in Europe.
Journal of hepatology 2008;48(1):148-62.
-
2008: Cubero Maria; Esteban Juan Ignacio; Otero Teresa; Sauleda Silvia; Bes Marta; Esteban Rafael; Guardia Jaume; Quer Josep
Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient.
Virology 2008;370(2):237-45.
-
2007: Lecube Albert; Hernández Cristina; Simó Rafael; Esteban Juan Ignacio; Genescà Joan
Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
The American journal of gastroenterology 2007;102(10):2189-95.
-
2007: Pradat P; Tillmann H L; Sauleda S; Braconier J-H; Saracco G; Thursz M; Goldin R; Winkler R; Alberti A; Esteban J-I; Hadziyannis S; Rizzetto M; Thomas H; Manns M P; Trepo C;
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
Journal of viral hepatitis 2007;14(8):556-63.
-
2007: Crespo M; Sauleda S; Esteban J I; Juarez A; Ribera E; Andreu A L; Falco V; Quer J; Ocaña I; Ruiz I; Buti M; Pahissa A; Esteban R; Guardia J
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.
Journal of viral hepatitis 2007;14(4):228-38.
-
2007: Zabaleta Aintzane; Arribillaga Laura; Llopiz Diana; Dotor Javier; Lasarte Juan J; Prieto Jesús; Borrás-Cuesta Francisco; Esteban Juan I; Quer Josep; Vayreda Francesc; Sarobe Pablo
Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Antiviral research 2007;74(1):25-35.
-
2007: Crespo Manuel; Esteban Juan I; Ribera Esteban; Falco Vicenç; Sauleda Silvia; Buti María; Esteban Rafael; Guardia Jaime; Ocaña Inma; Pahissa Albert
Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients.
AIDS (London, England) 2007;21(4):477-81.
-
2007: Crespo Manuel; Pou Leonor; Esteban Juan I; Falcó Vicenç; Ribera Esteban; Lopez Rosa; Sauleda Silvia; Curran Adriá; Villar del Saz Sara; Feijoo María; Ocaña Inma; Pahissa Albert
Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients.
Antiviral therapy 2007;12(8):1217-23.
-
2006: Simó Rafael; Lecube Albert; Genescà Joan; Esteban Joan Ignaci; Hernández Cristina
Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.
Diabetes care 2006;29(11):2462-6.
-
2006: Sauleda S; Martorell M; Esteban J I; Tural C; Ruiz I; Puig L; Esteban R; Guardia J; Vargas V
Hepatotoxicity of antiretroviral drugs in HIV HCV patients with congenital coagulopathies followed at an Haemophilia Unit during a decade.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(3):228-36.
-
2006: Tanaka Yasuhito; Kurbanov Fuat; Mano Shuhei; Orito Etsuro; Vargas Victor; Esteban Juan I; Yuen Man-Fung; Lai Ching-Lung; Kramvis Anna; Kew Michael C; Smuts Heidi E; Netesov Sergey V; Alter Harvey J; Mizokami Masashi
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality.
Gastroenterology 2006;130(3):703-14.
-
2006: Castells Lluis; Esteban Juan I; Bilbao Itxarone; Vargas Victor; Allende Helena; Ribera Esteban; Piron Maria; Sauleda Silvia; Len Oscar; Pahissa Albert; Esteban Rafael; Guardia Jaime; Margarit Carlos
Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
Antiviral therapy 2006;11(8):1061-70.
-
2005: Quer Josep; Esteban Juan Ignacio; Cos Joan; Sauleda Sílvia; Ocaña Laura; Martell María; Otero Teresa; Cubero Maria; Palou Eduard; Murillo Pedro; Esteban Rafael; Guàrdia Jaume
Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infection.
Journal of virology 2005;79(24):15131-41.
-
2005: Ocaña L; Cos J; Quer J; Bilbao I; Palou E; Parra R; Sauleda S; Esteban J I; Guàrdia J; Massuet L I; Margarit C
Analysis of INF-gamma, TNF-alpha and dendritic cells to predict hepatitis C virus recurrence in liver transplant patients.
Transplantation proceedings 2005;37(9):3951-6.
-
2005: Quer Josep; Cos Joan; Murillo Pedro; Esteban Juan Ignacio; Esteban Rafael; Guardia Jaume
Improved attachment of natural HCV isolate to Daudi cells upon elimination of immune complexes and close pH control.
Intervirology 2005;48(5):285-91.
-
2004: Lecube Albert; Hernández Cristina; Genescà Joan; Esteban Joan I; Jardí Rosend; García Lydia; Simó Rafael
Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection.
Diabetes care 2004;27(11):2669-75.
-
2004: Pradat Pierre; Maynard Marianne; Buti Maria; Berthillon Pascale; Picchio Gaston; Tillmann Hans L; Wiegand Johannes; Voirin Nicolas; Manns Michael P; Esteban Juan-Ignacio; Martinot Michèle; Marcellin Patrick; Trepo Christian
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment.
Journal of medical virology 2004;73(3):392-6.
-
2004: Lecube Albert; Hernández Cristina; Genescà Joan; Esteban Joan I; Jardí Rosend; Simó Rafael
High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury.
Diabetes care 2004;27(5):1171-5.
-
2004: Quer J; Murillo P; Martell M; Gómez J; Esteban J I; Esteban R; Guardia J
Subtype mutations in the envelope 2 region including phosphorylation homology domain of hepatitis C virus do not predict effectiveness of antiviral therapy.
Journal of viral hepatitis 2004;11(1):45-54.
-
2004: Martell María; Briones Carlos; de Vicente Aránzazu; Piron María; Esteban Juan I; Esteban Rafael; Guardia Jaime; Gómez Jordi
Structural analysis of hepatitis C RNA genome using DNA microarrays.
Nucleic acids research 2004;32(11):e90.
-
2003: Córdoba Juan; Flavià Montse; Jacas Carlos; Sauleda Silvia; Esteban Juan Ignacio; Vargas Víctor; Esteban Rafael; Guardia Jaume
Quality of life and cognitive function in hepatitis C at different stages of liver disease.
Journal of hepatology 2003;39(2):231-8.
-
2003: Berasain Carmen; Herrero José-Ignacio; García-Trevijano Elena R; Avila Matías A; Esteban Juan Ignacio; Mato José M; Prieto Jesús
Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function.
Hepatology (Baltimore, Md.) 2003;38(1):148-57.
-
2003: Quer Josep; Murillo Pedro; Esteban Juan Ignacio; Martell Maria; Esteban Rafael; Guardia Jaime
Sexual transmission of hepatitis C virus from a patient with chronic disease to his sex partner after removal of an intrauterine device.
Sexually transmitted diseases 2003;30(5):470-1.
-
2003: Córdoba Juan; Reyes Josep; Esteban Juan Ignacio; Hernández José Manuel
Labeling may be an important cause of reduced quality of life in chronic hepatitis C.
The American journal of gastroenterology 2003;98(1):226-7.
-
2002: Pradat Pierre; Alberti Alfredo; Poynard Thierry; Esteban Juan-Ignacio; Weiland Ola; Marcellin Patrick; Badalamenti Salvatore; Trépo Christian
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study.
Hepatology (Baltimore, Md.) 2002;36(4 Pt 1):973-7.
-
2002: Nadal Anna; Martell María; Lytle J Robin; Lyons Alita J; Robertson Hugh D; Cabot Beatriz; Esteban Juan I; Esteban Rafael; Guardia Jaime; Gómez Jordi
Specific cleavage of hepatitis C virus RNA genome by human RNase P.
The Journal of biological chemistry 2002;277(34):30606-13.
-
2002: Castro F J; Esteban J I; Juárez A; Sauleda S; Viladomiu L; Martell M; Moreno F; Allende H; Esteban R; Guardia J
Early detection of nonresponse to interferon plus ribavirin combination treatment of chronic hepatitis C.
Journal of viral hepatitis 2002;9(3):202-7.
-
2002: Sauleda S; Juárez A; Esteban J I
[Treatment of chronic hepatitis C in patients with HIV-coinfection]
Gastroenterología y hepatología 2002;25(5):337-41.
-
2001: Cabot B; Martell M; Esteban J I; Piron M; Otero T; Esteban R; Guardia J; Gómez J
Longitudinal evaluation of the structure of replicating and circulating hepatitis C virus quasispecies in nonprogressive chronic hepatitis C patients.
Journal of virology 2001;75(24):12005-13.
-
2001: Sauleda S; Juárez A; Esteban J I; Altisent C; Ruiz I; Puig L; Esteban R; Guardia J
Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders.
Hepatology (Baltimore, Md.) 2001;34(5):1035-40.
-
2001: Martell M; Gómez J; Esteban J I
[Molecular biology in the study of hepatitis C virus]
Gastroenterología y hepatología 2001;24 Suppl 1():1-6.
-
2001: Castro F J; Sauleda S; Esteban J I; Viladomiu L; Martell M; Dragon E; Esteban R; Guardia J
Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays.
Journal of virological methods 2001;91(1):51-8.
-
2001: Piquer S; Hernández C; Enriquez J; Ross A; Esteban J I; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
The Journal of laboratory and clinical medicine 2001;137(1):38-42.
-
2000: Touzet S; Kraemer L; Colin C; Pradat P; Lanoir D; Bailly F; Coppola R C; Sauleda S; Thursz M R; Tillmann H; Alberti A; Braconier J H; Esteban J I; Hadziyannis S J; Manns M P; Saracco G; Thomas H C; Trépo C
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research.
European journal of gastroenterology & hepatology 2000;12(6):667-78.
-
2000: Sauleda S; Esteban J I; Altisent C; Puig L; Esteban R; Guardia J
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
Thrombosis and haemostasis 2000;83(6):807-10.
-
2000: Pradat P; Chossegros P; Bailly F; Pontisso P; Saracco G; Sauleda S; Thursz M; Tillmann H; Vlassopoulou H; Alberti A; Braconier J H; Esteban J I; Hadziyannis S; Manns M; Rizzetto M; Thomas H C; Trépo C
Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy.
Journal of viral hepatitis 2000;7(3):203-10.
-
2000: Castro F J; Esteban J I; Sauleda S; Viladomiu L; Dragon E A; Esteban R; Guardia J
Utility of early testing for HCV viremia as predictive factor of sustained response during interferon or interferon plus ribavirin treatment.
Journal of hepatology 2000;32(5):843-9.
-
2000: Infante D; Pich M; Tormo R; Sauleda S; Montané C; Esteban J I; Esteban R
Prevalence of hepatitis G virus in healthy children in liver disease, and human immunodeficiency virus-1 infection: response to interferon.
Journal of pediatric gastroenterology and nutrition 2000;30(4):385-90.
-
2000: Cabot B; Martell M; Esteban J I; Sauleda S; Otero T; Esteban R; Guàrdia J; Gómez J
Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver.
Journal of virology 2000;74(2):805-11.
-
1999: Sauleda S; Reesink H J; Esteban J I; Hess G; Esteban R; Guardia J
Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus.
Journal of medical virology 1999;59(1):45-51.
-
1999: Sauleda S; Esteban J I; Hernandez J M; Reesink H; Castella D; Quer J; Hess G; Esteban R; Guardia J
Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus-infected blood.
Transfusion 1999;39(6):633-8.
-
1999: Martell M; Gómez J; Esteban J I; Sauleda S; Quer J; Cabot B; Esteban R; Guardia J
High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.
Journal of clinical microbiology 1999;37(2):327-32.
-
1999: Gómez J; Martell M; Quer J; Cabot B; Esteban J I
Hepatitis C viral quasispecies.
Journal of viral hepatitis 1999;6(1):3-16.
-
1998: Esteban J I; Cordoba J; Sauleda S
The clinical picture of acute and chronic hepatitis C.
Current studies in hematology and blood transfusion 1998;(62):102-18.
-
1997: Tacke M; Schmolke S; Schlueter V; Sauleda S; Esteban J I; Tanaka E; Kiyosawa K; Alter H J; Schmitt U; Hess G; Ofenloch-Haehnle B; Engel A M
Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
Hepatology (Baltimore, Md.) 1997;26(6):1626-33.
-
1997: Cabot B; Esteban J I; Martell M; Genescà J; Vargas V; Esteban R; Guardia J; Gómez J
Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions.
Journal of virology 1997;71(2):1732-4.
-
1996: Esteban J I; Gómez J; Martell M; Cabot B; Quer J; Camps J; González A; Otero T; Moya A; Esteban R
Transmission of hepatitis C virus by a cardiac surgeon.
The New England journal of medicine 1996;334(9):555-60.
-
1995: Camps J; Córdoba J; Esteban J I
Pathophysiology of hepatitis C virus infection.
Pathologie-biologie 1995;43(8):691-702.
-
1995: Buti M; Jardí R; Cotrina M; Rodríguez-Frías F; Troonen H; Viladomiu L; Esteban J I; Esteban R; Guardia J
Hepatitis E virus infection in acute hepatitis in Spain.
Journal of virological methods 1995;55(1):49-54.
-
1995: González A; Esteban J I; Madoz P; Viladomiu L; Genesca J; Muñiz E; Enríquez J; Torras X; Hernández J M; Quer J
Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.
Hepatology (Baltimore, Md.) 1995;22(2):439-45.
-
1995: Genescà J; Vila J; Córdoba J; Sauleda S; Quer J; Esteban J I; Esteban R; Piera L; Guardia J
Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication.
Journal of hepatology 1995;22(3):272-7.
-
1994: Martell M; Esteban J I; Quer J; Vargas V; Esteban R; Guardia J; Gómez J
Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation.
Journal of virology 1994;68(5):3425-36.
-
1994: Vargas V; Comas P; Castells L; Quer J; Esteban J I; Allende E; Esteban R; Guardia J; Margarit C
Incidence and outcome of hepatitis C virus infection after liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S216-20.
-
1994: Córdoba J; Camps J; Esteban J I
The clinical picture of acute and chronic hepatitis C.
Current studies in hematology and blood transfusion 1994;(61):69-88.
-
1993: Genesca J; Esteban J I; Quer J; Viladomiu L L; Gonzalez A; Esteban R; Guardia J
Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.
Gut 1993;34(2 Suppl):S62-3.
-
1992: Viladomiu L; Genescà J; Esteban J I; Allende H; González A; López-Talavera J C; Esteban R; Guardia J
Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial.
Hepatology (Baltimore, Md.) 1992;15(5):767-9.
-
1992: Martell M; Esteban J I; Quer J; Genescà J; Weiner A; Esteban R; Guardia J; Gómez J
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.
Journal of virology 1992;66(5):3225-9.
-
1992: Esteban J I; Lopez-Talavera J C; Genescà J; Gonzalez A; Vargas V; Buti M; Guardia J; Esteban R
Evaluation of anti-HCV positive blood donors identified during routine screening.
Archives of virology. Supplementum 1992;4():244-6.
-
1992: Esteban J I; Genesca J; Alter H J
Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features, and prevention.
Progress in liver diseases 1992;10():253-82.
-
1991: Esteban J I; López-Talavera J C; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
Annals of internal medicine 1991;115(6):443-9.
-
1991: Genesca J; Esteban J I; Alter H J
Blood-borne non-A, non-B hepatitis: hepatitis C.
Seminars in liver disease 1991;11(2):147-64.
-
1990: Esteban J I; González A; Hernández J M; Viladomiu L; Sánchez C; López-Talavera J C; Lucea D; Martin-Vega C; Vidal X; Esteban R
Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
The New England journal of medicine 1990;323(16):1107-12.
-
1990: López-Talavera J C; Allende H; Esteban R; Villegas G; Esteban J I; Guardia J
[Diagnosis of acute hepatitis caused by herpes simplex virus using in situ hybridization]
Medicina clínica 1990;94(9):342-3.
-
1990: Vargas V; Castells L; Esteban J I
High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma.
Annals of internal medicine 1990;112(3):232-3.
-
1990: Roget M; Buti M; Esteban J I; Esteban R; Guardia J
The presence of anti-HCV antibodies in the serum of patients with chronic active hepatitis and antinuclear antibodies.
Hepatology (Baltimore, Md.) 1990;11(2):333-5.
-
1989: Buti M; Esteban R; Jardi R; Rodriguez-Frias F; Casacuberta J; Esteban J I; Allende E; Guardia J
Chronic delta hepatitis: detection of hepatitis delta virus antigen in serum by immunoblot and correlation with other markers of delta viral replication.
Hepatology (Baltimore, Md.) 1989;10(6):907-10.
-
1989: Esteban J I; Esteban R; Viladomiu L; López-Talavera J C; González A; Hernández J M; Roget M; Vargas V; Genescà J; Buti M
Hepatitis C virus antibodies among risk groups in Spain.
Lancet 1989;2(8658):294-7.
-
1988: Buti M; Esteban R; Roggendorf M; Fernandez J; Jardi R; Rashofer R; Allende H; Genesca J; Esteban J I; Guardia J
Hepatitis D virus RNA in acute delta infection: serological profile and correlation with other markers of hepatitis D virus infection.
Hepatology (Baltimore, Md.) 1988;8(5):1125-9.
-
1987: Genesca J; Jardi R; Buti M; Vives L; Prat S; Esteban J I; Esteban R; Guardia J
Hepatitis B virus replication in acute hepatitis B, acute hepatitis B virus-hepatitis delta virus coinfection and acute hepatitis delta superinfection.
Hepatology (Baltimore, Md.) 1987;7(3):569-72.
-
1987: Buti M; Esteban R; Jardi R; Esteban J I; Guardia J
Serological markers for delta hepatitis.
Lancet 1987;1(8536):815.
-
1987: Buti M; Esteban R; Esteban J I; Allende H; Jardi R; Guardia J
Anti-HD IgM as a marker of chronic delta infection.
Journal of hepatology 1987;4(1):62-5.
-
1987: Viladomiu L; Genesca J; Esteban J I; Esteban R; Hernandez J M; Guardia J
When should at-risk infants be boosted with hepatitis B vaccine?
Lancet 1987;1(8523):49.
-
1987: Genescà J; Esteban J I; Esteban R; Hernández J M; Guardia J
Lack of HIV transmission after hepatitis B immunoprophylaxis.
Infection 1987;15(5):366.
-
1986: Genescá J; Esteban J I; Esteban R; Butí M; Muñiz R; Seijo G; Hernández J M; Guardia J
[Intrafamilial diffusion of the hepatitis B virus. A study of familial contacts of chronic carriers]
Medicina clínica 1986;87(7):271-4.
-
1986: Esteban J I; Genesca J; Esteban R; Hernandez J M; Seijo G; Buti M; Muniz R; Guardia J
Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area.
Journal of medical virology 1986;18(4):381-91.
-
1986: Guardia J; Esteban R; Buti M; Jardí R; Allende H; Esteban J I
Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitis.
Liver 1986;6(2):118-22.
-
1986: Buti M; Esteban R; Jardí R; Esteban J I; Guardia J
Serological diagnosis of acute delta hepatitis.
Journal of medical virology 1986;18(1):81-5.
-
1986: Esteban R; Buti M; Esteban J I; Hernández J M; Jardí R; Vila M; Tusell J; Guardia J
[HTLV-III infection in risk groups]
Medicina clínica 1986;86(3):110-2.
-
1984: Esteban R; Guardia J; Buti M; Esteban J I; Rodrigo M J; Jardí R; Hernández J M; Bacardí R
[IgM antibodies against hepatitis B core antigens, anti-HBc-IgM. Their diagnostic significance]
Medicina clínica 1984;83(11):437-9.
Sign-in to see more
